Top compounds associated with response to ACTL6B

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	serdemetan:SCH-529074 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.21	2e-08
mRNA	BRD-K34222889	CTRPv2	pan-cancer	AAC	0.19	2e-08
mRNA	CCT036477	CTRPv2	pan-cancer	AAC	0.19	3e-08
mRNA	GW-2580	GDSC1000	pan-cancer	AAC	0.21	3e-08
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.21	3e-08
mRNA	prima-1	CTRPv2	pan-cancer	AAC	0.18	8e-08
mRNA	Cetuximab	GDSC1000	pan-cancer	AAC	-0.19	8e-08
mRNA	Cytarabine	GDSC1000	pan-cancer	AAC	-0.2	8e-08
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.18	1e-07
mRNA	PD-0325901	GDSC1000	pan-cancer	AAC	-0.19	2e-07

Download CSV